Facing Competition News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bloomberg says Johnson & Johnson's exit from the race to make a respiratory syncytial virus vaccine for adults leaves open a $10 billion market. Separately, the WHO warned that the world has "arrived in the post-antibiotic era" over a lack of development of new drugs capable of tackling deadly superbugs.

United statesUnited kingdomSouth carolinaNorth carolinaJeffrey heierVance fowlerJeffrey mottsAndrew obenshainKarin conde knapeNovo nordiskDrug administrationUs fish wildlife serviceFacing competitionWildlife serviceChief executive officer andrew obenshainUnited nations backed